HEALTHY AIMS - Nano scale materials and sensors and microsystems for medical implants improving health and quality of life (FP6-IST) (2003-12-01 - 2007-11-30) (»add to infobox)

N. N. EUROPEAN TECHNOLOGY FOR BUSINESS LIMITED, N. N. ALBERT-LUDWIGS-UNIVERSITAET FREIBURG, N. N. ASSUTA MEDICAL CENTERS LTD., N. N. CAMPUS MICRO TECHNOLOGIES GMBH, N. N. CENTRAL RESEARCH LABORATORIES LIMITED, N. N. COCHLEAR EUROPE LIMITED, N. N. ECOLE POLYTECHNIQUE FEDERALE DE LAUSANNE, N. N. FINETECH MEDICAL LIMITED, N. N. HAHN-SCHICKARD-GESELLSCHAFT FUER ANGEWANDTE FORSCHUNG E.V., N. N. IIP - TECHNOLOGIES GMBH, N. N. INSTITUTE OF ELECTRON TECHNOLOGY, N. N. INTERUNIVERSITAIR MIKRO-ELEKTRONICA CENTRUM VZW, N. N. MEDIPLUS LIMITED, N. N. MICROTEC GESELLSCHAFT FUR MIKROTECHNOLOGIES MBH, N. N. N/A (1170837), N. N. NEXUS ASSOCIATION, N. N. NORTH BRISTOL NATIONAL HEALTH SERVICE TRUST, N. N. QUEEN MARY & WESTFIELD COLLEGE, N. N. SAFT S.A., N. N. SALISBURY HEALTH CARE NATIONAL HEALTH SERVICE TRUST, N. N. TWI LIMITED, N. N. UNIVERSITAET WIEN, N. N. UNIVERSITAT ROVIRA I VIRGILI, N. N. UNIVERSITY OF NEWCASTLE UPON TYNE, N. N. UNIVERSITY OF SALFORD, N. N. VDI/VDE- TECHNOLOGIEZENTRUM INFORMATIONSTECHNIK GMBH, N. N. ZARLINK SEMICONDUCTOR LIMITED

EUROPEAN TECHNOLOGY FOR BUSINESS LIMITED (UK511 - Bedfordshire) (Great Britain), ALBERT-LUDWIGS-UNIVERSITAET FREIBURG (DE131 - Freiburg im Breisgau, Stadtkreis) (Germany), ASSUTA MEDICAL CENTERS LTD. (ME04 - Israel) (Israel), CAMPUS MICRO TECHNOLOGIES GMBH (DE501 - Bremen, Kreisfreie Stadt) (Germany), CENTRAL RESEARCH LABORATORIES LIMITED (UK403 - Suffolk) (Great Britain), COCHLEAR EUROPE LIMITED (UK550 - Greater London) (Great Britain), ECOLE POLYTECHNIQUE FEDERALE DE LAUSANNE (CH011 - Vaud) (Switzerland), FINETECH MEDICAL LIMITED (UK512 - Hertfordshire) (Great Britain), HAHN-SCHICKARD-GESELLSCHAFT FUER ANGEWANDTE FORSCHUNG E.V. (DE136 - Schwarzwald-Baar-Kreis) (Germany), IIP - TECHNOLOGIES GMBH (DEA22 - Bonn, Kreisfreie Stadt) (Germany), INSTITUTE OF ELECTRON TECHNOLOGY (PL075 - Mazowieckie Miasto na Prawach Powiatu) (Poland), INTERUNIVERSITAIR MIKRO-ELEKTRONICA CENTRUM VZW (BE242 - Arr. Leuven) (Belgium), MEDIPLUS LIMITED (UK522 - Buckinghamshire) (Great Britain), MICROTEC GESELLSCHAFT FUR MIKROTECHNOLOGIES MBH (DEA12 - Duisburg, Kreisfreie Stadt) (Germany), N/A (1170837) (NoRegion - NoRegion) (Belgium), NEXUS ASSOCIATION (FR714 - Isère) (France), NORTH BRISTOL NATIONAL HEALTH SERVICE TRUST (UK611 - Avon) (Great Britain), QUEEN MARY & WESTFIELD COLLEGE (UK550 - Greater London) (Great Britain), SAFT S.A. (FR106 - Seine-Saint-Denis) (France), SALISBURY HEALTH CARE NATIONAL HEALTH SERVICE TRUST (UK613 - Wiltshire) (Great Britain), TWI LIMITED (UK401 - Cambridgeshire) (Great Britain), UNIVERSITAET WIEN (AT130 - Wien) (Austria), UNIVERSITAT ROVIRA I VIRGILI (ES514 - Tarragona) (Spain), UNIVERSITY OF NEWCASTLE UPON TYNE (UK132 - Tyne And Wear) (Great Britain), UNIVERSITY OF SALFORD (UK820 - Greater Manchester) (Great Britain), VDI/VDE- TECHNOLOGIEZENTRUM INFORMATIONSTECHNIK GMBH (DE40E - Potsdam-Mittelmark) (Germany), ZARLINK SEMICONDUCTOR LIMITED (UK613 - Wiltshire) (Great Britain)

In this project key microsystem technologies and communication methods will be developed that bring intelligence directly to the human, in the form of medical implants and ambulatory measurement systems, and also enable information from these devices to be transmitted out into the wider environment. The microsystem technologies to be developed can be applied to any generic Ambient Intelligent system comprising sensors, actuators, an intelligent processor and a wiring loom. The medical applications have been chosen for 2 reasons. Firstly, they will progress the existing State of the Art in Microsystems in terms of size, reliability, and power constraints far more than many other application sectors. In addition, there will be a direct positive impact into the health of EU citizens. The overall objective is to develop the technologies that go to make up a microsystem, and then produce specific medical devices to exploit these technologies. The 4-year project, with 27 partners, is structured with the focus on the microsystem technology development, most of which does not include silicon. This is seen as crucial if complete microsystems are to be realised in the coming few years. This project includes participants from all of the disciplines necessary to produce a complete generic microsystem. The result will be a range of core technologies and medical devices utilising these core technologies. Intelligence will be given back to people where part of their own internal system has failed. Quality of life will be improved for millions of EU citizens and the long term cost of treating people will reduce significantly. The resulting final medical products include cochlear and retina implants, nerve stimulation, bladder control and pressure monitoring systems. It is estimated from the available statistics that around 50% of the western population i.e. around 500 million citizens, will suffer from at least one of the health problems targeted in this project.

PERSONS (27/27)

RELATED NAVIGATION AREA(S) (3/3)